RVMD Fair Value — Revolution Medicines Inc

Biotechnology · Institutional-depth multi-model valuation on Equity Rank

Current Price
$187.50
Consensus Fair Value
$169.18
Margin of Safety
-9.8%

When does RVMD report earnings?

Revolution Medicines Inc (RVMD) is next scheduled to report earnings on Aug 5, 2026. The consensus analyst EPS estimate for the upcoming quarter is $-1.90.

Heading into this report, the model's fair value estimate sits 9.8% below the current price (model fair value differential below current price). Descriptive context only — not a forecast of the earnings result.

Earnings dates and estimates are sourced from third-party data and may change or lag. Informational only.

How RVMD's valuation models agree

Equity Rank computed model fair value for RVMD from 1 independent valuation methods with sufficient data. 0 place fair value above the current price of $187.50, and 1 place it below. The model-blended estimate lands at $169.18 — a model fair value differential of 9.8% below the current price under these model assumptions. The larger group places fair value below the current price.

Models: FV above price
0
Models: FV below price
1
Models compared
1

Each method (DCF, Graham Number, EPV, Three-Stage DCF, DDM, Residual Income, Justified Price-to-Book, and more) is weighted by historical sector accuracy. Model-derived and informational only — not investment advice.

RVMD fundamental profile

Equity Rank's fundamental strength composite scores RVMD at 34.9/100 (D+, Mixed), blending profitability, balance-sheet, and cash-flow quality. Its SAVE composite score has moved +0.4 over the past 30 days.

A composite quality metric for research context — not a rating, recommendation, or directional signal.

About RVMD

Revolution Medicines Inc (RVMD) is analyzed on Equity Rank using the S·A·V·E framework: Sentiment, Analyst consensus, Valuation (DCF, Graham, multiples), and Earnings quality. The consensus fair value is a blend of multiple models designed to surface potential mispricings versus current market price.

Equity Rank provides institutional-depth valuation research on 3,000+ US equities. Data is refreshed daily and combines quantitative models with AI-driven qualitative analysis.

Related Stocks in Biotechnology

JNJ · UNH · PFE · ABBV · MRK

Research Tools

Intrinsic Value Calculator · DCF Calculator · Margin of Safety Calculator